sellWeak10b5-1 plan
GAUGLER DARYL sold $9,880 of PCRX
Chief Operating Officer at Pacira BioSciences, Inc.. 500 shares at an average of $19.76, traded Dec 13, 2024, filed Dec 16, 2024.
Warning score
0Value
$9,880
500 shares
Holdings after
115,200
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001396814-24-000143, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | SOpen-market sale Common Stock10b5-1 | -500 | $19.76 | $9,880 | 115,200 | Dec 16, 2024 |
Related signals
Other insiders at Pacira BioSciences, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | PCRX Pacira BioSciences, Inc. | RIKER LAUREN Senior Vice President, Finance | $218k | 6,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.